Ask for the Oncotype DX Test to Help With Your Treatment Decision

If you have been diagnosed with DCIS (non-invasive) breast cancer (Stage 0) or early-stage invasive breast cancer (Stage I-IIIa), you may be eligible for the Oncotype DX breast cancer test, a unique genomic breast cancer test that looks at the activity of certain genes in your tumor to provide personalized information not available from any other test or measure. 

  • If you have early-stage invasive breast cancer, the Oncotype DX test is the only test that can help you find out if chemotherapy is the best treatment for you—or if there is an option that might suit you better.
  • If you have DCIS, the Oncotype DX test can help to determine the risk of your cancer returning – a key factor in deciding your treatment after surgery.

The Oncotype DX breast cancer test is included in all major cancer treatment guidelines around the world, is widely covered by insurers, and is recognized as the new standard of care.


Take the Eligibility Quiz

Find out if you are a candidate for the Oncotype DX breast cancer test by taking a simple and informative eligibility quiz. Learn More »


Questions to Ask Your Doctor

The decision of whether or not to order the Oncotype DX breast cancer test is one that you and your doctor should make together. You can download a discussion guide for use in talking with your doctor about the Oncotype DX test. Learn More »


Talk to Our Team

The Genomic Health team is committed to supporting you in your quest for information that will help you make the best possible treatment decision. Learn More »